ExploreWatchlistsPricing
  1. JP-listed companies
  2. 3-D Matrix,Ltd.
  3. Financials
  4. Stockholders' equity

3-D Matrix,Ltd. (7777)

Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Apr 30, 20252,216+527.27%
Apr 30, 2024353-32.67%
Apr 30, 2023525-64.00%
Apr 30, 20221,458-12.18%
Apr 30, 20211,660+250.90%
Apr 30, 2020473-68.74%
Apr 30, 20191,513-31.29%
Apr 30, 20182,202-15.55%
Apr 30, 20172,607-33.75%
Apr 30, 20163,936-38.33%
Apr 30, 20156,382+103.66%
Apr 30, 20143,133

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat